Education
About Us
Working with TipRanks
Follow Us
Biotron Limited (BITRF)
:BITRF
BITRF Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.05
Previous CloseN/A
Volume100.00K
Average Volume (3M)66.00
Market Cap
$1.74M
Enterprise Value$1.78M
Total Cash (Recent Filing)$878.88K
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta2.48
Next Earnings
Aug 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,327,245,800
10 Day Avg. Volume0
30 Day Avg. Volume66
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)4.34
Price to Sales (P/S)0.00
P/FCF Ratio14.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Biotron Limited News
PremiumCompany Announcements
Biotron Advances Hepatitis B Drug Development with Successful Safety Study
PremiumCompany Announcements
Biotron Announces Change of Share Registry Address
PremiumCompany Announcements
Biotron Limited Announces Investor Webinar to Discuss Recent Developments
PremiumCompany Announcements
Biotron Limited Announces Change in Company Secretary
PremiumCompany Announcements
Biotron Limited Announces Director’s Interest Change
PremiumCompany Announcements
Biotron Limited Completes Successful Rights Issue to Fund Antiviral ProgramsPremiumCompany Announcements
Biotron Limited Launches $2.7 Million Rights IssueOptions Prices
Currently, No data available
---
Ownership Overview
2.89%
Insiders
― Other Institutional Investors
97.11% Public Companies and
Individual Investors
BITRF FAQ
What was Biotron Limited’s price range in the past 12 months?
Biotron Limited lowest stock price was <$0.01 and its highest was $0.05 in the past 12 months.
What is Biotron Limited’s market cap?
Biotron Limited’s market cap is $1.74M.
When is Biotron Limited’s upcoming earnings report date?
Biotron Limited’s upcoming earnings report date is Aug 29, 2025 which is in 53 days.
How were Biotron Limited’s earnings last quarter?
Biotron Limited released its earnings results on Feb 28, 2025. The company reported <$0.001 earnings per share for the quarter, beating the consensus estimate of N/A by <$0.001.
Is Biotron Limited overvalued?
According to Wall Street analysts Biotron Limited’s price is currently Overvalued.
Does Biotron Limited pay dividends?
Biotron Limited does not currently pay dividends.
What is Biotron Limited’s EPS estimate?
Biotron Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biotron Limited have?
Biotron Limited has 1,327,245,800 shares outstanding.
What happened to Biotron Limited’s price movement after its last earnings report?
Biotron Limited reported an EPS of <$0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Biotron Limited?
Currently, no hedge funds are holding shares in BITRF
Biotron Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
BITRF Sentiment 70%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $37.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-119.28%
Trailing 12-Months
Asset Growth
-65.03%
Trailing 12-Months
Company Description
Biotron Limited
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.
Vectus Biosystems Limited
―
Regeneus Ltd.
―
AdAlta Ltd.
―
Bio-Gene Technology Ltd.
―
Hexima Ltd
―